Paradoxically, FGF-21 is elevated in various pathological conditions such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease [28,29,30,31,32,33,34], a phenomenon often interpreted as FGF-21 resistance or a compensatory response to chronic metabolic stress [35]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.